Efficacy and safety of ustekinumab in patients with refractory Crohn's disease: data from a real world study in Brazil

被引：0
|
作者：
Rogerio, Parra [1 ]
Julio, Chebli [2 ]
Liliana, Chebli [3 ]
Erika, Bertges [3 ]
Antonio Jose, Alves Junior [4 ]
Junior Orlando, Ambrogini [5 ]
Tarcia, Gomes [6 ]
Marley, Feitosa [1 ]
Omar, Feres [1 ]
Joaquim, Rocha Jose [1 ]
机构：
[1] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Surg & Anat, Ribeirao Preto, SP, Brazil
[2] Univ Fed Juiz de Fora, Ctr Inflammatory Bowel Dis, Juiz De Fora, Brazil
[3] Univ Fed Juiz de Fora, Juiz De Fora, Brazil
[4] Reis Neto Clin, Campinas, SP, Brazil
[5] Hosp Israelita Albert Einstein, Sao Paulo, Brazil
[6] Univ Fed Sao Paulo, Sao Paulo, Brazil
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2019年 / 114卷
关键词：
D O I：
10.14309/01.ajg.0000578228.17072.6c
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P039
引用
收藏
页码：S11 / S11
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Ustekinumab in Patients With Crohn's disease: Data From a Real World Study in Brazil
    Parra, Rogerio
    Chebli, Julio
    Chebli, Liliana
    Bertges, Erika
    Antonio Jose, Alves Junior
    Gomes, Tarcia
    Ambrogini Junior, Orlando
    Rocha, Jose Joaquim
    Feres, Omar
    Feitosa, Marley
    Azevedo, Matheus
    Queiroz, Natalia
    Schiavetti, Bianca
    Lubini, Marcio
    Argollo, Marjorie
    Gasparetti, Newton, Jr.
    Vilella, Eduardo
    Flores, Cristina
    Bafutto, Mauro
    Boratto, Sandra
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S17 - S17
  • [2] Efficacy of ustekinumab in patients with anti-TNF refractory Crohn's disease: data from a real-world study in Brazil
    Parra, R. S.
    Feitosa, M. R.
    Feres, O.
    Ribeiro da Rocha, J. J.
    Chebli, J. M. F.
    Chebli, L.
    Bertges, E. R.
    Gomes, T. N. F.
    Ambrogini, O., Jr.
    Alves Junior, A. J. T.
    Lubini, M.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S341 - S342
  • [3] Efficacy and safety of ustekinumab in Crohn's disease: A real-world study from Australia
    Ramaswamy, P. Kakkadasam
    Moattar, H.
    Sawyer, E.
    Edwards, J.
    Shukla, D.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S564 - S565
  • [4] EFFICACY AND SAFETY OF USTEKINUMAB IN CROHN'S DISEASE: A REAL-WORLD STUDY FROM THE WEST MIDLANDS
    Mozdiak, Ella
    Aleem, Muhammad Junaid
    Alhamamy, Noor
    Kalkat, Harkaran
    Port, Saskia
    Rupra, Roshan
    Sharma, Naveen
    Monga, Muhammad Ali
    Andrew, Mark
    GUT, 2021, 70 : A109 - A110
  • [5] Real-world data on efficacy and safety of ustekinumab in patients with Crohn's disease at a tertiary health service
    Rajagopalan, A.
    Menon, S.
    So, K.
    Venugopal, K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 150 - 150
  • [6] EFFICACY AND SAFETY OF USTEKINUMAB IN PATIENTS WITH MODERATE TO SEVERE CROHN'S DISEASE IN BRAZIL
    Prra, Rogerio S.
    Chebli, Julio
    Chebli, Liliana
    Bertges, Erika R.
    Ambrogini Junior, Orlando
    Schiavetti, Bianca
    Alves, Antonio, Jr.
    Flores, Cristina
    Lubini, Marcio
    Gasparetti, Newton, Jr.
    Bafutto, Mauro
    Azevedo, Matheus
    Damiao, Aderson O.
    Queiroz, Natalia S.
    Steinwurz, Flavio
    Carvalho, Nayara S.
    Boratto, Sandra D.
    Vilela, Eduardo G.
    Feres, Omar
    Rocha, Jose Joaquim R.
    GASTROENTEROLOGY, 2021, 160 (06) : S414 - S415
  • [7] Real-world effectiveness and safety of ustekinumab for the treatment of refractory Crohn's disease: The Scottish ustekinumab cohort
    Plevris, N.
    Robertson, A.
    Fulforth, J.
    Hall, R.
    Campbell, I.
    Kane, C.
    Veryan, J.
    Lam, W.
    Saunders, J.
    Jenkinson, P.
    Chuah, C.
    Kelly, C.
    Watts, D.
    Gaya, D.
    Macdonald, J.
    Jafferbhoy, H.
    Seenan, J. P.
    Mowat, C.
    Sutherland, D.
    Naismith, G.
    Bain, G.
    Arnott, I.
    Jones, G.
    Lees, C.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S484 - S484
  • [8] Editorial: accumulating data about ustekinumab in refractory Crohn's disease in real world experience
    Khorrami, S.
    Gisbert, J. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (10) : 1374 - 1375
  • [9] Real-World Efficacy And Safety Of Ustekinumab And Adalimumab In Patients With Crohn's Disease: Propensity Matched Analysis
    Shin, Y.
    Hong, S. N.
    Kim, E. R.
    Chang, D. K.
    Kim, Y. H.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 842 - 842
  • [10] Real-World Effectiveness and Safety of Ustekinumab in Elderly Crohn’s Disease Patients
    Rajat Garg
    Manik Aggarwal
    Robert Butler
    Jean Paul Achkar
    Bret Lashner
    Jessica Philpott
    Benjamin Cohen
    Taha Qazi
    Florian Rieder
    Miguel Regueiro
    Benjamin Click
    Digestive Diseases and Sciences, 2022, 67 : 3138 - 3147
12345